BILIBILI INC-SPONSORED ADR (BILI) Fundamental Analysis & Valuation

NASDAQ:BILI • US0900401060

Current stock price

23.76 USD
-0.01 (-0.04%)
At close:
23.77 USD
+0.01 (+0.04%)
After Hours:

This BILI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BILI Profitability Analysis

1.1 Basic Checks

  • In the past year BILI was profitable.
  • BILI had negative earnings in 4 of the past 5 years.
  • In multiple years BILI reported negative operating cash flow during the last 5 years.
BILI Yearly Net Income VS EBIT VS OCF VS FCFBILI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B -4B 6B -6B

1.2 Ratios

  • BILI's Return On Assets of 2.90% is fine compared to the rest of the industry. BILI outperforms 62.32% of its industry peers.
  • BILI has a Return On Equity of 7.66%. This is in the better half of the industry: BILI outperforms 75.36% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.46%, BILI is in line with its industry, outperforming 59.42% of the companies in the same industry.
Industry RankSector Rank
ROA 2.9%
ROE 7.66%
ROIC 3.46%
ROA(3y)-5.25%
ROA(5y)-9.35%
ROE(3y)-11.8%
ROE(5y)-23.17%
ROIC(3y)N/A
ROIC(5y)N/A
BILI Yearly ROA, ROE, ROICBILI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • With a decent Profit Margin value of 3.93%, BILI is doing good in the industry, outperforming 62.32% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 3.71%, BILI is in line with its industry, outperforming 57.97% of the companies in the same industry.
  • BILI has a worse Gross Margin (36.62%) than 75.36% of its industry peers.
  • In the last couple of years the Gross Margin of BILI has grown nicely.
Industry RankSector Rank
OM 3.71%
PM (TTM) 3.93%
GM 36.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y27.72%
GM growth 5Y9.12%
BILI Yearly Profit, Operating, Gross MarginsBILI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

2

2. BILI Health Analysis

2.1 Basic Checks

  • BILI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BILI has less shares outstanding
  • The number of shares outstanding for BILI has been increased compared to 5 years ago.
  • BILI has a worse debt/assets ratio than last year.
BILI Yearly Shares OutstandingBILI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BILI Yearly Total Debt VS Total AssetsBILI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

  • BILI has a Debt/Equity ratio of 0.62. This is a neutral value indicating BILI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.62, BILI is doing worse than 69.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.68
WACC5.08%
BILI Yearly LT Debt VS Equity VS FCFBILI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that BILI should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.36, BILI is not doing good in the industry: 63.77% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.36 indicates that BILI should not have too much problems paying its short term obligations.
  • BILI has a Quick ratio of 1.36. This is in the lower half of the industry: BILI underperforms 63.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
BILI Yearly Current Assets VS Current LiabilitesBILI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

6

3. BILI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 8628.57% over the past year.
  • The Revenue has grown by 13.10% in the past year. This is quite good.
  • BILI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.39% yearly.
EPS 1Y (TTM)8628.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.31%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y11.49%
Revenue growth 5Y20.39%
Sales Q2Q%7.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 31.33% on average over the next years. This is a very strong growth
  • BILI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.55% yearly.
EPS Next Y19.82%
EPS Next 2Y25.38%
EPS Next 3Y28.28%
EPS Next 5Y31.33%
Revenue Next Year10.26%
Revenue Next 2Y9.86%
Revenue Next 3Y9.57%
Revenue Next 5Y9.55%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BILI Yearly Revenue VS EstimatesBILI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
BILI Yearly EPS VS EstimatesBILI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20 30

2

4. BILI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 27.31, BILI can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as BILI.
  • The average S&P500 Price/Earnings ratio is at 26.86. BILI is around the same levels.
  • BILI is valuated rather expensively with a Price/Forward Earnings ratio of 22.68.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BILI.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, BILI is valued a bit cheaper.
Industry RankSector Rank
PE 27.31
Fwd PE 22.68
BILI Price Earnings VS Forward Price EarningsBILI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BILI Per share dataBILI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • BILI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BILI's earnings are expected to grow with 28.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.38
PEG (5Y)N/A
EPS Next 2Y25.38%
EPS Next 3Y28.28%

0

5. BILI Dividend Analysis

5.1 Amount

  • BILI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BILI Fundamentals: All Metrics, Ratios and Statistics

BILIBILI INC-SPONSORED ADR

NASDAQ:BILI (4/10/2026, 8:07:56 PM)

After market: 23.77 +0.01 (+0.04%)

23.76

-0.01 (-0.04%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)03-05
Earnings (Next)05-11
Inst Owners9.44%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner Change0%
Market Cap9.68B
Revenue(TTM)30.35B
Net Income(TTM)1.19B
Analysts84.86
Price Target31.25 (31.52%)
Short Float %3.53%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.39%
Min EPS beat(2)5.62%
Max EPS beat(2)23.15%
EPS beat(4)4
Avg EPS beat(4)18.95%
Min EPS beat(4)5.62%
Max EPS beat(4)41.24%
EPS beat(8)7
Avg EPS beat(8)13.18%
EPS beat(12)10
Avg EPS beat(12)11.3%
EPS beat(16)13
Avg EPS beat(16)8.72%
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)0.31%
Revenue beat(8)2
Avg Revenue beat(8)-0.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)1.33%
PT rev (3m)2.41%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-6.91%
EPS NY rev (1m)-11.72%
EPS NY rev (3m)-11.56%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)0.74%
Revenue NY rev (3m)0.74%
Valuation
Industry RankSector Rank
PE 27.31
Fwd PE 22.68
P/S 2.18
P/FCF N/A
P/OCF N/A
P/B 4.25
P/tB 6.86
EV/EBITDA N/A
EPS(TTM)0.87
EY3.66%
EPS(NY)1.05
Fwd EY4.41%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.9
BVpS5.6
TBVpS3.47
PEG (NY)1.38
PEG (5Y)N/A
Graham Number10.47
Profitability
Industry RankSector Rank
ROA 2.9%
ROE 7.66%
ROCE 5.4%
ROIC 3.46%
ROICexc 57.36%
ROICexgc N/A
OM 3.71%
PM (TTM) 3.93%
GM 36.62%
FCFM N/A
ROA(3y)-5.25%
ROA(5y)-9.35%
ROE(3y)-11.8%
ROE(5y)-23.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y27.72%
GM growth 5Y9.12%
F-ScoreN/A
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z N/A
F-ScoreN/A
WACC5.08%
ROIC/WACC0.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8628.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.31%
EPS Next Y19.82%
EPS Next 2Y25.38%
EPS Next 3Y28.28%
EPS Next 5Y31.33%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y11.49%
Revenue growth 5Y20.39%
Sales Q2Q%7.59%
Revenue Next Year10.26%
Revenue Next 2Y9.86%
Revenue Next 3Y9.57%
Revenue Next 5Y9.55%
EBIT growth 1Y183.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year297.49%
EBIT Next 3Y83.93%
EBIT Next 5Y45.18%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BILIBILI INC-SPONSORED ADR / BILI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BILIBILI INC-SPONSORED ADR?

ChartMill assigns a fundamental rating of 3 / 10 to BILI.


Can you provide the valuation status for BILIBILI INC-SPONSORED ADR?

ChartMill assigns a valuation rating of 2 / 10 to BILIBILI INC-SPONSORED ADR (BILI). This can be considered as Overvalued.


Can you provide the profitability details for BILIBILI INC-SPONSORED ADR?

BILIBILI INC-SPONSORED ADR (BILI) has a profitability rating of 3 / 10.


What is the earnings growth outlook for BILIBILI INC-SPONSORED ADR?

The Earnings per Share (EPS) of BILIBILI INC-SPONSORED ADR (BILI) is expected to grow by 19.82% in the next year.